Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Exelixis Enters into Collaboration with Merck to Evaluate Zanzalintinib for Cancer Treatment
Tuesday, October 15, 2024Exelixis and Merck have entered a clinical development partnership to investigate the combination of Exelixis investigational tyrosine kinase inhibitor TKI zanzalintinib with Mercks therapiesHead and neck cancer includes a range of tumors that develo...
MEDiC Life Sciences Enters into Collaboration with Hanmi Pharmaceutical for Cancer Biomarker Research and Investment
Tuesday, October 15, 2024MEDiC Life Sciences has announced a research collaboration with Hanmi Pharmaceutical The MCAT platform MEDiCs nextgeneration functional genomics system is designed to measure millions of genedrug interactions between cancer therapies and genetic muta...
UCB Secures FDA Approval for 320 mg Single-injection BIMZELX® Device
Monday, October 14, 2024UCB has received approval from the US Food and Drug Administration FDA for new mL prefilled syringe and prefilled autoinjector options each containing mg of BIMZELX bimekizumabbkzx Bimekizumabbkzx is a humanized monoclonal antibody that targets the...
AstraZeneca and Daiichi Sankyo’s Enhertu Approved in China as First HER2-Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC)
Monday, October 14, 2024AstraZeneca and Daiichi Sankyos Enhertu has gained conditional approval in China as a standalone treatment for adults with unresectable locally advanced or metastatic nonsmall cell lung cancer NSCLC featuring activating HER ERBB mutations
Roche Gains FDA Approval for Itovebi in Advanced HR-Positive, HER2-Negative Breast Cancer with PIK3CA Mutation
Friday, October 11, 2024Roche announced that the United States Food and Drug Administration FDA has approved Itovebi inavolisib for use in combination with palbociclib Ibrance and fulvestrant HRpositive breast cancer which accounts for about of all breast cancer cases ofte...
Ono Enters into Agreements with LigaChem for LCB97 and Novel ADC Development
Friday, October 11, 2024Ono Pharmaceutical has announced a license agreement with LigaChem Biosciences for the development of LCB a preclinical stage antibodydrug conjugate ADC targeting solid tumours The ConjuAll ADC platform addresses common limitations in current ADC
Arbele Enters into Collaboration with BioAI on AI-Driven Precision Oncology
Thursday, October 10, 2024Arbele has announced new strategic collaborations with BioAI in precision oncology utilizing artificial intelligence AI to advance targeted immunotherapeutics including bispecific Tcell engagers TCEs and antibodydrug conjugates ADCs
Ono Pharma's Opdivo Approved with Cisplatin and Gemcitabine for Unresectable or Metastatic Urothelial Carcinoma
Thursday, October 10, 2024Ono Pharmaceutical has received approval from the Taiwan Food and Drug Administration TFDA for the expanded use of Opdivo nivolumab in combination with cisplatin and gemcitabineOpdivo an immune checkpoint inhibitor enhances the bodys immune system by...
Boehringer Ingelheim Enters into Collaboration with Circle Pharma on New Precision Cancer Treatment
Thursday, October 10, 2024Boehringer Ingelheim has entered into a research collaboration and licensing agreement with Circle Pharma to develop a novel cyclin inhibitor aimed at halting cancer cell growthThis initiative is designed to provide a new treatment option for individ...
Teva's Biosimilar to Prolia® (Denosumab) Accepted for Review by U.S. FDA and EU EMA
Wednesday, October 09, 2024Teva Pharmaceutical Industries has announced that the US Food and Drug Administration FDA has accepted and the European Medicines Agency EMA has validated applications for TVBP a biosimilar candidate to Prolia denosumab
